Tenosynovial biopsy during carpal tunnel release (CTR) leads to an earlier diagnosis of amyloidosis. Surgery for trigger digit—trigger release (TR)—may provide a similar opportunity. We sought to characterize the risk of amyloidosis diagnosis after TR and/or CTR.